NCT02425059

Irreversible Electroporation(IRE) For Unresectable Rectal Neoplasms

Irreversible Electroporation(IRE) For Unresectable Rectal Neoplasms: Phase I and Phase II Clinical Trial

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 30 (actual)
• Sponsor: Fuda Cancer Hospital, Guangzhou · Academic / Other
• Sex: All
• Age: 18 Years – 80 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to evaluate the safety and efficacy of irreversible electroporation (IRE) for unresectable Rectal Neoplasms.

Detailed description

By enrolling patients with unresectable Rectal Neoplasms adapted to enrolled criteria, this study will document for the first time the safety and the short and long term efficacy of percutaneous IRE for unresectable Rectal Neoplasms.

Conditions

• Rectal Neoplasms

Interventions

Type	Name	Description
PROCEDURE	Irreversible electroporation (IRE)	Irreversible Electroportion For Unresectable Rectal Neoplasms guide with ultrasound or/and CT.
DEVICE	NanoKnife

Timeline

• Start date: 2015-01-01
• Primary completion: 2020-12-01
• Completion: 2021-02-01
• First posted: 2015-04-23
• Last updated: 2021-09-05

Locations

1 site across 1 country: China